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For over two score years there has been an increasing interest in the effects of oophorectomy on mammary carcinoma, both primary and metastatic. For more than half of that period the medical liter ature on radiation therapy has seen a sub stantial increase in the bibliography on radiation castration for metastatic breast cancer, more especially as regards the ef fects of such a procedure on the secondary deposits in bone. The encouraging regres sions of the skeletal metastases from mammary carcinoma following castration in women, still menstruating, have sug gested the possibility that orchiectomy might retard or even cause regression of mammary cancer in the maleâ€"both in the primary and metastatic lesions. The latter experiment was begun more than two years ago at the Memorial Hospital and was noted in a preliminary report four months after the first patient was other cases for such therapy by surgery have been collected. In 1942 Farrow and Woodard I were led to observe the effects of the adminis tration of androgens and estrogens on the serum calcium in patients with skeletal metastases from breast cancer. Impressed by the favorable results obtained in the retardation of the growth of osseous me tastases in mammary carcinoma by radia tion castration, they studied the effects of â€oe¿ chemical castrationâ€• by the injections of testosterone propionate. They found that the three patients who received such ther apy had developed increased blood cal cium in the urine. The chemical changes were accompanied by clinical and roent genographic evidence of increased activity in the metastatic disease in bone. The ad ministration of estrogens was found to produce a similar effect. They inferred, therefore, that the ability of the male and female sex hormones to cause hypercal cemia in such cases was due to the stimu lation by the hormones of the growth of the metastatic tumor. However, this find ing is at variance with the observations of Dobriner and of Abels2 who administered to each of two patients a total of three grams of both crystalline testosterone and testosterone propionate without produc ing a stimulating effect on the primary or metastati@ disease or increasing signifi cantly the calcium level of the blood.
The observations that the use of an drogens and estrogens in women with breast carcinoma was deleterious, the nu merous favorable results in inoperable and metastatic carcinoma produced by X-ray castration and the older reports on surgical castration for inoperable breast cancer, suggested that castration be tried in males. Farrow and Adair3 observed the results of orchiectomy on osseous me tastases from breast carcinoma. Their patient has been reported previously, but only four months after operation, and is the first of the six subjects in the present communication.
Enough time has now elapsed to evaluate fully the overall effects of orchiectomy. At the time orchiectomy was performed the clinical classification of the six cases under report was primary operable, one; prophylactic, one; recur rent inoperable, one; primary inoperable, three.
The consent for orchiectomy, even in the elderly male with advanced breast can cer was most difficult to obtain. It appears to be a triumph of medical persuasion to obtain permission for this operation. Even an elderly male with the intense pain from osseous metastases was unwilling to un dergo castration. The famale who in her psychological make-up expects the cli macteric at one time or another is more easily persuaded to submit to oophorec tomy than is the male who rarely, if ever, expects a complete cessation of his sexual functions. It seems to be more difficult to obtain permission for castration in males suffering from mammary cancer than in malignant disease of the prostate.
The Clinical Results of Bilateral Orchiectomy
The following summary has been based on an analysis of the six patients who had bilateral orchiectomy and whose histories are analyzed in the Table. To In Case I, a 72-year-old male with widespread metastases to bone, was cas trated on February 9, 1942. He had prompt relief from pain and has been comfortable since that time. Skeletal metastases have shown marked reparative change; all the pathological fractures in bone having healed with a firm callus which subse quently ossified. His general condition is good; he is in an excellent state of nutri tion; the blood chemistry has returned to normal. One of the most striking results in this case has been the continued regres sion in the primary cancer of the left breast. The ulcerating tumor has now been com pletely replaced by a cicatnix. However, at the present time there is some question of reactivation especially in the skull. Twenty-eight months have elapsed since castration.
In Case 3, the patient submitted to castration on May 8, 1943 , and was re lieved promptly of the pain caused by metastases to the lower dorsal and lumbar vertebrae. While his blood chemistry never showed an abnormally high rise, his pre operative alkaline phosphatase of 6.6 units now is 2.6 units. X-ray films show evidence of bone regeneration.
There has been a gain in weight. No evidence of local re currence is noted nor are there new areas of metastasis and the pain has been com pletely relieved â€"¿ avery gratifying clinical result 13 months after bilateral orchiec tomy.
The third case with a favorable result has now gone one year after castration. He was the only primary operable patient in the group and his breast cancer was treated only by local excision and bilateral orchiectomy.
This unusual approach to the control of mammary carcinoma in the male has resulted in the following observations: (1)A radical axillary dissection 10 months after local excision and castration revealed no evidence of metastasis to the axillary nodes. (2)There has been no recurrence at the site of the local excision and the pa tient has not developed distant metastatic areas to date. However, one cannot be certain that local excision alone might have controlled the tumor process.
In Case 6, patient was castrated in January 1944, following the discovery of definite pulmonary metastases on his ini tial visit to the clinic. Five months after operation there has been a noticeable de crease in the extent and character of the pulmonary metastases. A single area of bone destruction in the crest of the right ilium has shown no further progression. The primary tumor in the breast has shown moderate healing and regression, but the axillary metastases have as yet shown no signs of alteration. There have been no significant changes in the blood chemistry. The patient has maintained his weight and is in good general condition.
Metabolic Effects of Orchiectomy
It is now a common observation that after orchiectomy, patients with carcinoma of the prostate which has metastasized to bone often show considerable clinical im provement. This benefit, as a rule, consists of a marked decrease of pain at the sites of skeletal metastases, increased appetite, gain in weight and muscular tone. Im provement of this nature, likewise, was noted to occur after operation in four of the six patients with breast cancer included inthepresent study.
The symptomatic change after orchi ectomy most likely is related to the hor mone imbalance effected by the surgical procedure. The nature of this imbalance isnot,ofcourse, clear, butitisreasonable to believe that metabolic changes are af fected by a decreased androgen formation or overactivity of naturally occurring es trogens. The latter assumption appears all themorelikely since theadministration of estrogens to patients with prostatic can cer metastatic to bone in many instances is attended by equal or better success than that induced by orchiectomy. 4 Since the administration of certain estrogens and other related steroids apparently can in duce characteristic metabolic changes, these alterations were sought for after orchiectomy in two of the six men with breast cancer and in an additional three patients with carcinoma of the prostate. In particular, measurements were made of the effects of the surgical proce dure on:
A. Fluid and electrolyte balance. Pre vious studies from this hospital have dem onstrated that the administration of a-es tradiol benzoate to women before and after the menopause and to men with prostatic cancer induces a significant rise in both extracellular water and plasma volume.5 It is interesting to note that a similar change results from the adminis tration of large amounts of testosterone and testosterone propionate.6 However, from 12 to 18 days after orchiectomy no significant change had occurred in the volume of extracellular water or plasma in two patients with cancer of the breast and one patient with carcinoma of the prostate. Likewise, in the two remaining patients with prostatic carcinoma in whom these measurements were made only three months after operation, the values ob tained were within normal limits. Further more, orchiectomy apparently had no persistent effect on the concentrations of sodium, potassium, calcium, bicarbqnate, phosphate, or chloride in the serum of the patients studied.
B. Nitrogen balance and protein fab rication. The now well known effect of certain androgens (principally testoster one and testosterone propionate) to induce nitrogen retention7 suggested that a tem porary negative nitrogen balance might be obtained in males subjected to castra tion. In a group of three individuals stud ied here (two with carcinoma of the breast and one with carcinoma of the prostate), nitrogen balance studies were made for from 12 to 18 days before and for a like period after operation. No change in ni trogen balance was found to have occurred in this time. The total circulating protein of these individuals, likewise, remained unaltered.
C. The urinary excretion of creatine.
Since testosterone and methyl testosterone especially appear to exert a considerable influence on the urinary excretion of crc atinet there was reason to believe that this function might be effected by the castra tion. This was not found to be the case in the two patients with breast cancer and the one patient with carcinoma of the prostate. Likewise, the two other individ uals with prostatic tumors excreted only normal amounts of creatine.
D. The utilization of carbohydrate. There is no satisfactory evidence that hor mones particularly potent as androgens or estrogens exert an influence on carbohy drate metabolism as do corticostrone or certain other steroids of adrenal cortical origin. Nevertheless, it appeared to be of interest to ascertain whether or not the hormone imbalance conceived to occur after orchiectomy might be reflected in an unusual carbohydrate utilization.
Accordingly, two patients with carcino ma of the breast and one patient with car cinoma of the prostate were maintained on consistent diets as described by Thorne.9 When these subjects were in nitrogen bal ance, an estimation of their carbohydrate metabolism was obtained from their in travenous glucose tolerance curves both before and after orchiectomy. These mea surements, made by the technique de scribed by Thorne and associates,9 failed to indicate any change in carbohydrate utilization after operation.
Summary
It would appear, therefore, that of the metabolic phases measured, none changed significantly in the 12 to 18 days after or chiectomy in the patients studied. Changes known to be induced by testosterone or a-estradiol apparently do not occur simul taneously with clinical symptomatic im provement in patients subjected to orchi ectomy. It seems probable that the regenerative capacity of the injured bone is stimulated by some one of the many endocrine changes associated with castration. The effect is notconfined tothemalesex, since we have also seen it in female patients with carci noma of the breast who have undergone either surgical or roentgen castration. The mechanism of this stimulation remains obscure.
Of the patients forming the subject of the present report, Case 1 showed changes in serum alkaline phosphatase very similar to those commonly seen in castrated pa tients with carcinoma of the prostate meta static to bone. The alkaline phosphatase was slightly elevated at 5.9 units per 100 cubic centimeters before castration, began to rise immediately after operation, and reached 11.0 units in three and a half months. It then dropped, reaching normal in one year and remaining within normal limits for another year. There was no strik ing increase in the degree of osteoplasia of the bone lesions, but the process was ar rested and some healing took place. The serum calcium and phosphorus were with in normal limits throughout, indicating that the rate of bone destruction was never very rapid. At present, 28 months after castration, the serum alkaline phosphatase has risen slightly, and there are X-ray in In Case 2 there was considerable eleva tion of the serum alkaline phosphatase throughout the period of observation. The patient probably had cirrhosis of the liver, and, in liver disease, alkaline phosphatase may be retained in the blood, instead of being excreted in the bile, as it normally is. Hence, in this case, the level of serum alkaline phosphatase cannot be taken as an index of bone activity. The serum cal cium, however, showed a highly signifi cant riseduring a-estradiol therapy. Before treatment the serum calcium was normal, varying between 10.9 and 11.4 milligrams per 100 cubic centimeters on three deter minations. It began to rise immediately
BIochemical Effects of Orchiectomy
Before the blood chemical findings on the present cases are discussed, it will be well to review the general significance of chem ical changes in patients with cancer meta static to bone. Alkaline phosphatase is produced in large amounts in bones which are attempting to repair damage. When cancer of soft part origin metastasizes to bone, the bone may or may not respond to the injury with the production of new osseous tissue. When an attempt at repair is made, the alkaline phosphatase of the serum rises and the metastases are osteo plastic. When, as in the majority of bone metastases from carcinoma of the breast, no attempt at repair is made, the alkaline phosphatase of the serum remains normal, and the lesions are osteolytic. If the pro cess of bone destruction is very rapid, the calcium and phosphorus of the serum may rise to high, or even dangerous, levels. Thus the alkaline phosphatase of the blood may be taken as an index of the rapidity of bone formation, and thecalcium and phosphorus of the blood as an index of the rapidity of bone destruction.
We have shown elsewhere' that treat ment with either testosterone propionate or with estrone caused an increase in the serum calcium of female patients with carcinoma of the breast metastatic to bone.
The increase was apparently due to in creased osteolysis caused by rapid growth of the tumor in the bone. It did not occur in patients with breast cancer who were without bone metastases.
Several investigators@@ 10,â€oe¿ have found that, when patients with carcinoma of the prostate metastatic to bone are orchiecto mized,theserum alkaline phosphatase, which is usually elevated before treatment, rises still higher. In our series, this rise occurred in two-thirds of the cases. A sim ilar rise was observed in patients treated with stilbestrol, but only in about one fourth of the cases. The increase was tem porary, persisting for only two or three months, and was followed by a drop to or below the initial level. The increase in the serum alkaline phosphatase was usu ally associated with an increase in the degree of osteoplasia of the bone lesions, In Case 3, patient showed occasional slight elevations in serum alkaline phos phatase and serum calcium, but the changes were too small to be significant.
In Case 5, patient showed, prior to castration, elevations in serum alkaline phosphatase (7.4 to 13.6 units per 100c.c.), in serum phosphorus (3.2 to 5.1 mgm. per 100 c.c.), and in urinary excretion of cal cium (420 to 580 mgm. every 24 hours). This appeared to indicate that osteolysis was rapid, as was also shown roentgeno graphically, but that some attempt at bone repair was being made. Immediately after castration there was a shift toward normal in all chemical findings, but this change lasted for only two weeks, after which there was a reversion to, or above, the former high levels. Simultaneously there was a deterioration in the clinical condition 200 400 600 800 Days of the patient. It is not clear whether the rise in alkaline phosphatase was a response to castration or whether it was caused by the increased activity of the metastatic deposits in the bones.
In Case 6, patient developed bone me tastases late in the period of observation.
His blood chemistry was normal except for a persistent borderline elevation in serum calcium. The elevation was too small to be considered definitely patho logical. Determinations of serum acid phos phatase were made at intervals on these patients, and no abnormalities were found. This was to be expected, since, as far as is known at present, serum acid phosphatase is never increased except in the presence of metastasizing carcinomaof the prostate.
Conclusion
We may summarize the clinical results of this study by stating that bilateral orchi ectomy may have been responsible for the temporary regression of the primary lesion In the histological examination of the testes of the six orchiectomized patients, essentially normal gonads were found. The mammary cancer had not metasta sized to the testicles. This is in striking contrast to the findings in 33 women who were castrated for therapeutic control of breast cancer. In this group, nine patients had mammary carcinoma metastatic to the ovaries.
The studies on two of the orchiecto mized patients led to a conclusion that of the metabolic phases measuredâ€"(l) fluid and electrolyte balance; (2) nitrogen bal ance and serum protein fabrication; (3) urinary excretion of creatine; and (4) the utilization of carbohydrate â€"¿ none changed in 12 to 18 days after operation. This failure to demonstrate changes known to be induced by the administration of testosterone or a-estradiol, shows that these changes are not necessary to produce clinical symptomatic improvement.
In one castrated patient the same changes in the serum alkaline phosphatase were seen which were observed regularly in patients with carcinoma of the prostate metastatic to bone following orchiectomy. In two castrated patients there were no conspicuous changes in the calcium, phos phorus, or alkaline phosphatase of the serum, and in one the findings indicated continuing progress of the disease. In the patient treated with a-estradiol there was a rise in serum calcium similar to that found in female patients with bone meta stases from carcinoma of the breast who have received estrogens. Thus, in this small series of patients, there is a marked lack of uniformity in the response to en docrine treatment of the blood changes caused by bone metastases. Further ob servation will be necessary before the cause of this variability can be determined.
We must call attention to the small number of cases under report. The value of the procedure will only be determined by observations on a larger group. @
